Akeega’s indicated usage now spans across mCSPC and mCRPC, widening the drug’s future market potential.

Johnson & Johnson's Akeega is opening new fronts in prostate cancer treatment with a fresh FDA approval making it the first ...

By the way, GSK, realizing its potential in the MSI-H/dMMR market, is actively developing it for the treatment of colon ...

Genetic risk models and variant classification tools are refining breast cancer risk assessment by identifying high-risk ...

The U.S. health regulator on Friday approved Innoviva's oral antibiotic to treat gonorrhea, a common sexually transmitted infection, offering patients an alternative to an injectable drug that was the ...